CHAM
REGN icon

Clear Harbor Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Clear Harbor Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Sell
7,610
-3,265
-30% -$2.22M 0.29% 74
2026
Q1 		$8.4M Buy
10,875
+311
+3% +$238K 0.58% 39
2025
Q4 		$8.15M Sell
10,564
-73
-0.7% -$49.6K 0.55% 41
2025
Q3 		$5.98M Buy
10,637
+2,218
+26% +$1.25M 0.41% 56
2025
Q2 		$4.42M Buy
8,419
+1,616
+24% +$902K 0.33% 69
2025
Q1 		$4.31M Buy
6,803
+1,382
+25% +$951K 0.34% 69
2024
Q4 		$3.86M Buy
5,421
+3,006
+124% +$2.52M 0.31% 72
2024
Q3 		$2.54M Buy
2,415
+21
+0.9% +$23.4K 0.21% 95
2024
Q2 		$2.52M Buy
2,394
+6
+0.3% +$5.82K 0.22% 95
2024
Q1 		$2.3M Buy
2,388
+22
+0.9% +$20.9K 0.2% 97
2023
Q4 		$2.08M Buy
2,366
+115
+5% +$94.7K 0.19% 97
2023
Q3 		$1.85M Sell
2,251
-8
-0.4% -$6.29K 0.19% 102
2023
Q2 		$1.62M Buy
2,259
+11
+0.5% +$8.48K 0.16% 113
2023
Q1 		$1.85M Buy
2,248
+10
+0.4% +$7.54K 0.19% 108
2022
Q4 		$1.61M Buy
2,238
+62
+3% +$45.7K 0.2% 95
2022
Q3 		$1.5M Sell
2,176
-20
-0.9% -$12.6K 0.21% 92
2022
Q2 		$1.3M Buy
2,196
+8
+0.4% +$5.2K 0.17% 102
2022
Q1 		$1.53M Buy
2,188
+247
+13% +$156K 0.17% 109
2021
Q4 		$1.23M Buy
1,941
+14
+0.7% +$8.61K 0.13% 137
2021
Q3 		$1.17M Buy
1,927
+133
+7% +$82.6K 0.02% 153
2021
Q2 		$1M Buy
1,794
+268
+18% +$136K 0.12% 146
2021
Q1 		$722K Buy
+1,526
New +$743K 0.09% 166

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Clear Harbor Asset Management's REGN Position: Q2 2026 in Review

Clear Harbor Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 30% in Q2 2026, selling an estimated $2.22M and leaving 7,610 shares worth $4.75M. The position accounts for 0.29% of the portfolio, ranked #74.

Clear Harbor Asset Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.4M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Clear Harbor Asset Management held 7,610 shares of Regeneron Pharmaceuticals worth $4.75M as of Q2 2026.
  • Clear Harbor Asset Management sold 3,265 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.22M.
  • Regeneron Pharmaceuticals made up 0.29% of Clear Harbor Asset Management's portfolio in Q2 2026, its #74 holding.
  • Clear Harbor Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Clear Harbor Asset Management's Regeneron Pharmaceuticals position peaked at $8.4M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.